CALVIN WESLEY YEE,JOHANNES CORNELIUS HERMANN,MICHAEL SOTH,RAMA K. KONDRU,ROBERT THAN HENDRICKS,SAUL JAIME-FIGUEROA,STEPHEN M. LYNCH,TIMOTHY D. OWENS,YAN LOU
申请号:
BR112012029437
公开号:
BR112012029437A2
申请日:
2011.05.17
申请国别(地区):
BR
年份:
2017
代理人:
摘要:
The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I, wherein the variables Q and R, R2, and R3 are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.